Project Grant K01HL179242
- This federal Project Grant award of $549,128 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to investigate early-life predictors of telomere length and its impact on the development of subclinical atherosclerosis. The grant will leverage data and biospecimens from the Southern California Children's Health Study to: 1) Determine the extent to which telomere length and its changes from birth to adulthood are affected by growth factors and...
- This $709,902 Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will support a study titled "SEX, HIV, AND AIR POLLUTION EFFECTS ON POST-TB LUNG DISEASE (SHAPE PTLD)". The goal is to establish a well-characterized cohort of post-tuberculosis lung disease (PTLD) patients in Uganda and investigate whether sex, HIV serostatus, and air pollution exposure are associated with distinct PTLD lung function and chest CT...
- This $176,220 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports a research project investigating interactions between genetics, air pollution exposure, and preschool-onset childhood asthma. The 5-year project, awarded on August 15, 2025, is led by the University of Wisconsin-Madison and aims to: Conduct a candidate gene association study for preschool-onset asthma, Identify genetic variants that interact with early-life...
- This Project Grant award of $804,982 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research on how race, ethnicity, and genetic ancestry contribute to complex traits and disease across diverse U.S. populations. The project will leverage the Trans-Omics for Precision Medicine (TOPMed) dataset, which includes whole genome sequencing, RNA-seq, metabolomics, and other multi-omic data for over 180,000...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $673,581 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Ochin, Inc., a nonprofit health IT organization based in Portland, Oregon. The project will assess disparities in asthma care utilization and outcomes between Latino and non-Hispanic white adults, and identify the underlying social determinants of health factors driving these disparities. The project will leverage Ochin's unique dataset...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $189,000 to the University of Colorado-Denver to investigate the role of outdoor air pollution and environmental allergens in driving treatment response for children with asthma exacerbations in the emergency department. The 2-year project aims to determine the association between these environmental factors and acute asthma treatment responsiveness. This work...
- This federal Project Grant award, provided by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), will fund research to evaluate how immigration status contributes to disparities in cardiometabolic health and accelerated epigenetic aging among Hispanic/Latino populations in the U.S. The $156,486 grant, awarded on Dec 11, 2024, will support the use of data from the California Health Interview Survey and the Hispanic Community Health Study/Study of Latinos...
- This Project Grant award of $254,250 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will be used by New York University (NYU) to study the relationship between neighborhood factors and sleep health disparities among first and second grade students, primarily Black children, in New York City. The study will merge NYU's proprietary longitudinal dataset on children's mental health and educational outcomes with the publicly available Child...
- This $1,057,905 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will fund a comprehensive research program to promote weight-related health and address the full spectrum of weight-related outcomes in the next generation of adolescents and young adults. The project, titled "PROMOTING WEIGHT-RELATED HEALTH IN THE NEXT GENERATION OF ADOLESCENTS AND YOUNG ADULTS," aims to understand the most salient issues facing...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $100,998 Project Grant under CFDA 93.837 - Cardiovascular Diseases Research to The Regents of the University of California, San Francisco (UCSF) to evaluate the effects of universal pre-kindergarten (pre-K) policies on parents' cardiovascular health and health inequities. The proposed research will leverage the National Health Interview Survey to examine the relationships between parenthood, universal pre-K access, and...
This $174,829 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will support a study on the implications of transit-oriented development (TOD) for childhood obesity and asthma in Los Angeles, California. The study aims to leverage the city's TOC program, which has produced nearly 10,000 affordable housing units, as a natural experiment to evaluate the impact of TOD on children's obesity, asthma, caregiver mental health, and physical activity outcomes. The research will also explore potential mechanisms underlying the TOD-health associations, such as impacts on housing affordability, transit use, and neighborhood environments. The project will utilize a mixed-methods approach, including quantitative analyses and qualitative interviews with caregivers, developers, and policymakers. Awarded on August 16, 2025, the project is slated for completion by July 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $174.8k | 8/12/25 |